lly glp 1 drug Diabetes Patients Also Struggle to Access GLP-1 Agonists LLY News | ELI LILLY

Victoza, a GLP-1 drug released in 2010, had side effects discovered about it, eventually resulting in official warning from the FDA in 2013

As our knowledge of GLP-1 biology advances and novel therapeutic innovations arise, these agents are expected to assume a progressively pivotal role in the management of metabolic disorders and their related complications, ultimately enhancing patient outcomes across various disease states

JAMA Open Network

Paraquat, a widely-used herbicide, has been linked to Parkinsons disease, leading to numerous Paraquat Parkinsons Disease Lawsuits against its manufacturers for failing to warn about the risks of chronic exposure